Zhu Z, Xu WB, Xu AQ, et al. Molecular epidemiological analysis of echovirus 19 isolated from an outbreak associated with hand, foot, and mouth disease (HFMD) in Shandong Province of China. Biomed Environ Sci. 2007 Aug. 20(4):321-8. [QxMD MEDLINE Link].
He SZ, Chen MY, Xu XR, Yan Q, Niu JJ, Wu WH, et al. Epidemics and aetiology of hand, foot and mouth disease in Xiamen, China, from 2008 to 2015. Epidemiol Infect. 2017 Apr 3. 1-10. [QxMD MEDLINE Link].
Yan XF, Gao S, Xia JF, Ye R, Yu H, Long JE. Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis. 2011 Dec 18. [QxMD MEDLINE Link].
Chan JH, Law CK, Hamblion E, Fung H, Rudge J. Best practices to prevent transmission and control outbreaks of hand, foot, and mouth disease in childcare facilities: a systematic review. Hong Kong Med J. 2017 Apr. 23 (2):177-90. [QxMD MEDLINE Link].
Yang C, Deng C, Wan J, Zhu L, Leng Q. Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Virol J. 2011. 8:306. [QxMD MEDLINE Link].
Lee TC, Guo HR, Su HJ, Yang YC, Chang HL, Chen KT. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J. 2009 Oct. 28(10):904-10. [QxMD MEDLINE Link].
Chung WH, Shih SR, Chang CF, Lin TY, Huang YC, Chang SC, et al. Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions. J Infect Dis. 2013 Dec. 208(12):1968-78. [QxMD MEDLINE Link].
Mathes EF, Oza V, Frieden IJ, Cordoro KM, Yagi S, Howard R, et al. "Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics. 2013 Jul. 132(1):e149-57. [QxMD MEDLINE Link].
Yu JG, Liu YD, Qiao LY, Wang CJ. [Epidemiological study and clinical analysis of 931 children with hand foot and mouth disease in Yantai]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct. 25(5):374-6. [QxMD MEDLINE Link].
Hayman R, Shepherd M, Tarring C, Best E. Outbreak of variant hand-foot-and-mouth disease caused by coxsackievirus A6 in Auckland, New Zealand. J Paediatr Child Health. 2014 Aug 15. [QxMD MEDLINE Link].
Vuorinen T, Osterback R, Kuisma J, Ylipalosaari P. Epididymitis caused by coxsackievirus A6 in association of hand, foot and mouth disease. J Clin Microbiol. 2014 Sep 17. [QxMD MEDLINE Link].
Jia HL, He CH, Wang ZY, et al. MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease. BMC Infect Dis. 2014 Sep 17. 14(1):506. [QxMD MEDLINE Link].
Li X, Li Q, Li J, et al. Elevated levels of circulating histones indicate disease activity in patients with hand, foot, and mouth disease (HFMD). Scand J Infect Dis. 2014 Sep 8. 1-8. [QxMD MEDLINE Link].
Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 2002 Jun. 109(6):e88. [QxMD MEDLINE Link]. [Full Text].
Chong CY, Chan KP, Shah VA, et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatr. 2003 Oct. 92(10):1163-9. [QxMD MEDLINE Link].
McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001 Jan 15. 32(2):236-42. [QxMD MEDLINE Link].
Ooi MH, Wong SC, Mohan A, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. 2009 Jan 19. 9:3. [QxMD MEDLINE Link]. [Full Text].
Kim SJ, Kim JH, Kang JH, Kim DS, Kim KH, Kim KH, et al. Risk factors for neurologic complications of hand, foot and mouth disease in the Republic of Korea, 2009. J Korean Med Sci. 2013 Jan. 28(1):120-7. [QxMD MEDLINE Link]. [Full Text].
Sutton-Hayes S, Weisse ME, Wilson NW, Ogershok PR. A recurrent presentation of hand, foot, and mouth disease. Clin Pediatr (Phila). 2006 May. 45(4):373-6.
Wei SH, Huang YP, Liu MC, Tsou TP, Lin HC, Lin TL. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis. 2011. 11:346. [QxMD MEDLINE Link].
Agrawal R, Bhan K, Balaggan K, Lee RW, Pavesio CE, Addison PK. Unilateral acute maculopathy associated with adult onset hand, foot and mouth disease: case report and review of literature. J Ophthalmic Inflamm Infect. 2015. 5:2. [QxMD MEDLINE Link].
Tsao KC, Chang PY, Ning HC, et al. Use of molecular assay in diagnosis of hand, foot and mouth disease caused by enterovirus 71 or coxsackievirus A 16. J Virol Methods. 2002 Apr. 102(1-2):9-14. [QxMD MEDLINE Link].
Zhang X, Yan HP, Huang C, et al. [The etiology and clinical manifestations of 70 patients with hand-foot-mouth disease]. Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Oct. 43(10):872-4. [QxMD MEDLINE Link].
Wang C, Chen Y, Xu T, Tian X, Zheng J, Liu W, et al. A novel method to diagnose the infection of enterovirus A71 in children by detecting IgA from saliva. J Med Virol. 2020 Jan 15. [QxMD MEDLINE Link].
Li J, Chen F, Liu T, Wang L. MRI Findings of Neurological Complications in Hand-Foot-Mouth Disease by Enterovirus 71 Infection. Int J Neurosci. 2012 Feb 20. [QxMD MEDLINE Link].
Yang Y, Wang H, Gong E, et al. Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People's Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study. Hum Pathol. 2009 Apr 22. [QxMD MEDLINE Link].
Lim H, In HJ, Lee JA, Sik Yoo J, Lee SW, Chung GT, et al. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease. Vaccine. 2018 Jun 7. 36 (24):3445-3452. [QxMD MEDLINE Link].
Gao L, Zou G, Liao Q, Zhou Y, Liu F, Dai B, et al. Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral diagnostic yield of different clinical samples. Clin Infect Dis. 2018 Apr 24. [QxMD MEDLINE Link].
Yang Y, Zhang L, Fan X, Qin C, Liu J. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo. Bioorg Med Chem Lett. 2012 Mar 15. 22(6):2209-11. [QxMD MEDLINE Link].
Liu J, Yang Y, Xu Y, Ma C, Qin C, Zhang L. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol J. 2011. 8:483. [QxMD MEDLINE Link].
Harada YU, Lekcharoensuk P, Furuta T, Taniguchi T. Inactivation of Foot-and-Mouth Disease Virus by Commercially Available Disinfectants and Cleaners. Biocontrol Sci. 2015. 20 (3):205-8. [QxMD MEDLINE Link].
Faulkner CF, Godbolt AM, DeAmbrosis B, Triscott J. Hand, foot and mouth disease in an immunocompromised adult treated with aciclovir. Australas J Dermatol. 2003 Aug. 44(3):203-6. [QxMD MEDLINE Link].
Toida M, Watanabe F, Goto K, Shibata T. Usefulness of low-level laser for control of painful stomatitis in patients with hand-foot-and-mouth disease. J Clin Laser Med Surg. 2003 Dec. 21(6):363-7. [QxMD MEDLINE Link].
Chen S, Yang Y, Yan X, Chen J, Yu H, Wang W. Influence of vitamin A status on the antiviral immunity of children with hand, foot and mouth disease. Clin Nutr. 2011 Dec 22. [QxMD MEDLINE Link].
Ruan F, Yang T, Ma H, Jin Y, Song S, Fontaine RE. Risk factors for hand, foot, and mouth disease and herpangina and the preventive effect of hand-washing. Pediatrics. 2011 Apr. 127(4):e898-904. [QxMD MEDLINE Link].
Li Y, Dang S, Deng H, Wang W, Jia X, Gao N, et al. Breastfeeding, previous Epstein-Barr virus infection, Enterovirus 71 infection, and rural residence are associated with the severity of hand, foot, and mouth disease. Eur J Pediatr. 2013 May. 172(5):661-6. [QxMD MEDLINE Link].
Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016 Jan 14. 1-8. [QxMD MEDLINE Link].
Harada Y, Lekcharoensuk P, Furuta T, Taniguchi T. Inactivation of Foot-and-Mouth Disease Virus by Commercially Available Disinfectants and Cleaners. Biocontrol Sci. 2015. 20 (3):205-8. [QxMD MEDLINE Link].
Jiang L, Wang J, Zhang C, He W, Mo J, Zeng J, et al. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China. Vaccine. 2020 Feb 11. 38 (7):1804-1809. [QxMD MEDLINE Link].